Hologic (NASDAQ:HOLX) reported an adjusted EPS of 34 cents during the first quarter of fiscal 2012, a couple of cents above the Zacks Consensus Estimate and 4 cents above the year-ago figure. Revenues were $472.7 million, an increase of 9.3% year over year and higher than the Zacks Consensus Estimate of $466 million.
Segments
Hologic operates through four segments − Breast Health, Diagnostics, GYN (Gynecology) Surgical and Skeletal Health − each contributing a corresponding 46%, 33%, 16% and 5% … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards